Featured Research

from universities, journals, and other organizations

Novel approach to regulating blood sugar levels in the body

Date:
May 19, 2013
Source:
University Health Network (UHN)
Summary:
For the first time, scientists showed that targeting glucagon action in the brain may be a new frontier for regulating diabetes.

For the first time, scientists at the Toronto General Research Institute showed that targeting glucagon action in the brain may be a new frontier for regulating diabetes.

Related Articles


An international team led by Senior Scientist Dr. Tony Lam showed how glucagon regulates the hypothalamus' control over blood sugar.

In experimental models of obesity and diabetes, researchers determined that resistance to glucagon in the brain leads to increases in blood sugar levels, a trait of these conditions. However, direct stimulation of the protein kinase A signaling pathways (PKA) in the brain bypasses the resistance and decreases blood sugar levels.

The study, entitled "Hypothalamic glucagon signaling inhibits hepatic glucose production" was published today in the on-line edition of the international journal, Nature Medicine. It paves the way for investigation of a potentially new way of decreasing blood sugar levels in diabetes and obesity, by increasing glucagon action in the brain.

Glucagon is a hormone secreted by the pancreatic islet α-cells when blood sugar levels fall too low. It is known that glucagon functions in the liver to cause blood sugar levels to increase. However, this increase is temporary and blood sugar levels return to normal. This decrease in blood sugar is thought to occur through glucagon action in the hypothalamus.

In diabetes, glucagon's transient increase in blood sugar is impaired and levels remain elevated. Currently, insulin is the most common means of regulating blood sugar levels in diabetics.

"Studying glucagon action in the in the brain is a totally new area of investigation for potential treatment of diabetes. Drugs that aim to increase glucagon action in the brain and/or block glucagon action in the liver could regulate sugar levels in diabetes," said Dr. Tony Lam, who holds the J.K.McIvor (1915-1942) Endowed Chair in Diabetes Research and Canada Research Chair in Obesity at the Toronto General Research Institute and the University of Toronto. Dr. Lam is also Associate Professor, Departments of Medicine and Physiology, University of Toronto, Associate Director, University of Toronto Banting and Best Diabetes Centre and Senior Scientist at the Toronto General Research Institute. "I believe that down the road, treating diabetes with glucagon therapy will be equally as effective as insulin therapy," Dr. Lam added.

The findings of this study pave the way for further investigation and will be the basis for future strategies for dealing with elevated blood sugar levels in diabetes and obesity.

The research was supported by the Canadian Diabetes Association.


Story Source:

The above story is based on materials provided by University Health Network (UHN). Note: Materials may be edited for content and length.


Journal Reference:

  1. Patricia I Mighiu, Jessica T Y Yue, Beatrice M Filippi, Mona A Abraham, Madhu Chari, Carol K L Lam, Clair S Yang, Nikita R Christian, Maureen J Charron, Tony K T Lam. Hypothalamic glucagon signaling inhibits hepatic glucose production. Nature Medicine, 2013; DOI: 10.1038/nm.3115

Cite This Page:

University Health Network (UHN). "Novel approach to regulating blood sugar levels in the body." ScienceDaily. ScienceDaily, 19 May 2013. <www.sciencedaily.com/releases/2013/05/130519145650.htm>.
University Health Network (UHN). (2013, May 19). Novel approach to regulating blood sugar levels in the body. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2013/05/130519145650.htm
University Health Network (UHN). "Novel approach to regulating blood sugar levels in the body." ScienceDaily. www.sciencedaily.com/releases/2013/05/130519145650.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins